Sun Pharmaceutical Moves To Buy Taro In $450 Million Deal

Sun Pharmaceutical has signed a definitive agreement to acquire Haifa, Israel-based Taro Pharmaceutical Industries in a deal valued at more than $450 million, the companies announced May 21

More from Archive

More from Scrip